Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Aravinda Galappatthige
Period: Reporting periods mapped to calendar 2025 Q1 – 2026 Q2 (6 quarters).
- Questions
- 9on tracked calls
- Challenge rate
- 0%none of 9 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 6with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 9 of 9 questions from 1 company
TRIThomson Reuters Corporation9 questions · 6 reporting periods · 0 of 9 challenging
Calendar 2026 Q2
vis-a-vis the competitors, the start-ups, any kind of head-to-head feedback that you can share
Show response
Hasker said the rebuilt fully agentic CoCounsel Legal is highly differentiated by native access to TR content and thousands of attorney editors, with strong early usage growth; the buyback question was deferred to Bischoping.
Calendar 2026 Q1
Is it -- correct me if I'm wrong, you bought back $262 million worth of shares as of March 31
Show response
Eastwood confirmed plan to complete remaining $338M buyback in Q2. No additional NCIB commitments announced but Board will discuss at June and September meetings. Additional returns are an option given strong balance sheet.
I forget, Mike, if you had given any numbers on adoption there, any targets or any sort of recent adoption numbers that you've quoted
Show response
Eastwood declined to share specific Westlaw Advantage adoption numbers, pointing instead to the broader AI-enabled ACV metric. Confirmed ACV penetration trending faster than prior Westlaw upgrade cycles with strong pipelines across all segments.
Calendar 2025 Q4
I was wondering if it's worthwhile differentiating the position with respect to your customers and larger law firms as opposed to the smaller law firms
Show response
Steve noted AI demand is uniquely even across firm sizes, sole litigators show same urgency as large firms, instantly seeing efficiency impact. Mike said GenAI ACV will steadily rise through 2026-2027 with potential spikes as more products get AI-enabled. Started at 15% in Q3 2024, now 28%.
Calendar 2025 Q3
Should we sort of take that forward even in the -- going into '26 that notwithstanding that framework, you have the ability and the willingness to sort of step up
Show response
Mike maintained $400-500M framework but highlighted willingness to step up as demonstrated by $1B NCIB completed in October. Will propose fifth consecutive 10% dividend increase at January board meeting.
Is it fair to sort of characterize the present sort of position as sort of getting close to peak in terms of new product launches
Show response
Steve said TR's innovation rate will accelerate, while general-purpose horizontal tools may flatten. Mike firmly stated: do not correlate margin expansion confidence with investing less. $200M+ AI investment will continue into 2026.
Calendar 2025 Q2
very strong EBITDA growth yet again, similar to what we saw in Q1. Perhaps for Mike, is that predominantly sort of that timing benefit
Show response
Mike confirmed SafeSend integration expenses shifted from Q2 to H2 drove the TAP margin outperformance. Full year TAP and Legal margins will be comparable within 1-2%.
Calendar 2025 Q1
I was wondering if has there been an uptick as we look at 2025. Or is it pretty much the same run rate
Show response
Mike confirmed a slight uptick in AI investment for 2025, split roughly 50-50 between OpEx and CapEx, all reflected in results and guidance.
I was wondering whether you could maybe just revisit the drafting side of the opportunity. I know that you launched the CoCounsel Drafting product last year. Maybe just remind us the TAM there
Show response
Steve described drafting as a big opportunity with TR differentiated by Westlaw and Practical Law content for accurate first drafts, but declined to give a specific TAM.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| TRI Thomson Reuters Corporation | 9 | 0%none of 9 questions |
- TRIThomson Reuters Corporation · 9 questions0%none of 9 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2025 Q1 | 2 | 0%none of 2 questions | 1 |
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | 2 | 0%none of 2 questions | 1 |
| 2025 Q4 | 1 | 0%none of 1 question | 1 |
| 2026 Q1 | 2 | 0%none of 2 questions | 1 |
| 2026 Q2 | 1 | 0%none of 1 question | 1 |
- 2025 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q41 question · challenge rate 0% (none of 1 question) · 1 company
- 2026 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2026 Q21 question · challenge rate 0% (none of 1 question) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Cloud & AI5
- Competitive Dynamics2
- Capital Allocation2
- Innovation & R&D2
- Capex Investment2
- Subscriber Growth1
- Demand1
- Margin1
- M&A1